StockWatch
·
Pharmaceuticals
Management Change5 Nov 2026, 11:01 pm

Sai Life Sciences Appoints New Senior Management Personnel

AI Summary

Sai Life Sciences Limited announced that its Board of Directors, during a meeting held on November 5, 2026, approved the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026. The board also approved the appointment of three individuals as Senior Management Personnel (SMP): Mr. Sidhartha Das as Senior Vice President & Head - Human Resources, Mr. Vijay Kumar Suthari as Vice President - Head Quality & Regulatory Affairs, and Mr. Sriram Gopalakrishnan as Senior Vice President - Corporate Communications, all effective from November 5, 2026. Additionally, the company approved the allotment of 27,005 and 81,000 equity shares under its ESOP 2008 and MESOP 2018 plans, respectively, leading to an increase in the paid-up equity share capital.

Key Highlights

  • Board approved Q2 & H1 FY27 unaudited financial results.
  • Appointed three new Senior Management Personnel (SMPs).
  • Approved allotment of equity shares under ESOP plans.
  • Issued and paid-up equity share capital increased.
  • Board meeting concluded within a short duration.